Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02264977 · ClinicalTrials.gov registry record · NA
Early Feasibility of the Branched TAG® Device in the Treatment of Aortic Arch Aneurysms
A NA study of Aneurysm of Aortic Arch, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 6
- Study locations
NCT02264977 is a NA study of Aneurysm of Aortic Arch that has completed, run by W.L.Gore & Associates. The registered enrollment target is 9 participants. The trial reports 6 study locations across 5 states.
The verdict
NCT02264977, a NA study of Aneurysm of Aortic Arch, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to assess the early feasibility of the use of the GORE® TAG® Thoracic Branch Endoprosthesis to treat aneurysms involving the aortic arch
Conditions Studied
Interventions
- DEVICE GORE® TAG® Thoracic Branch Endoprosthesis
Study Locations (6)
Pennsylvania
- Hospital at University of Pennsylvania - Philadelphia
- Univerisity of Pittsburgh Medical Center - Pittsburgh
California
- Leland Stanford Junior University - Stanford
Michigan
- University of Michigan - Ann Arbor
Minnesota
- Mayo Clinic Rochester - Rochester
New Hampshire
- The Hitchcock Foundation (Dartmouth Hitchcock Medical Center) - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-04 |
| Est. Completion | 2022-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02264977
The ClinicalTrials.gov registry entry for NCT02264977 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aneurysm of Aortic Arch appearing as the primary indexed condition, and to 1 intervention - of which GORE® TAG® Thoracic Branch Endoprosthesis is the first listed.
NCT02264977 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Pennsylvania, California, Michigan.
Frequently Asked Questions
What is clinical trial NCT02264977 about?
NCT02264977 is a clinical study titled "Early Feasibility of the Branched TAG® Device in the Treatment of Aortic Arch Aneurysms". The purpose of this study is to assess the early feasibility of the use of the GORE® TAG® Thoracic Branch Endoprosthesis to treat aneurysms involving the aortic arch
What is the current status of trial NCT02264977?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2015-04. Estimated completion is 2022-03.
What conditions does trial NCT02264977 study?
This clinical trial studies the following conditions: Aneurysm of Aortic Arch.
What interventions are being tested in trial NCT02264977?
The interventions under investigation include: GORE® TAG® Thoracic Branch Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT02264977?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02264977 being conducted?
This trial has 6 study locations across California, Michigan, Minnesota, New Hampshire, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.